Feldan brings series A total to $13.8M

Feldan Therapeutics Inc. (Quebec, Quebec) raised an additional $1.3 million from Asahi Kasei Corporate Venture Capital on Nov. 27 for its series A round, bringing the round's total to $13.8 million. Felden will use the funds to develop its Shuttle peptide-based delivery system to introduce proteins into cells.

In September, Felden raised $12.5 million in the A round led by new investor Green Cross Corp. (KSE:006280). New investor Stonebridge Ventures also participated, as did existing investors Anges Québec and Anges Québec Capital, plus undisclosed existing investors...